期刊文献+

外水相组成对醋酸戈舍瑞林PLGA微球理化性质的影响

Effect of external aqueous phase composition on the physicochemical properties of goserelin acetate PLGA microspheres
下载PDF
导出
摘要 目的 采用W/O/W和O/W乳化溶剂挥发法制备醋酸戈舍瑞林PLGA微球,考察在外部水相中加入不同浓度的氯化钠和甘露醇对所制备微球理化性质的影响。方法 醋酸戈舍瑞林PLGA微球采用W/O/W和O/W乳化溶剂挥发法制备,以微球的表面形态、内部形态、粒径、载药量、体外累计释放行为、结构和晶型来评价不同浓度的添加剂对两种制备方法所制得微球的影响。结果 采用W/O/W制备的微球增加外水相中氯化钠的浓度,微球载药量增加、粒径减小、突释量降低、微球表面及内部孔洞减少;增加外水相中甘露醇的浓度,微球载药量增加、粒径减小,突释量降低、微球表面孔洞减少,内部孔洞未减少;O/W法制备的微球增加水相中氯化钠和甘露醇的浓度,微球载药量增加、粒径减小、突释量降低、微球表面及内部孔洞减少。结论 通过增加外部水相中添加剂的浓度,有效改善了醋酸戈舍瑞林PLGA微球的结构和性质。 Objective To determine the effect of sodium chloride and mannitol in the outer aqueous phase on the physicochemical properties of the goserelin acetate PLGA microspheres.Methods Goserelin acetate PLGA microspheres were prepared by W/O/W and O/W emulsion-solvent evaporation methods.The effects of different concentrations of sodium chloride and mannitol on the microspheres were evaluated in terms of surface morphology,internal morphology,particle size,drug loading,in vitro release,structure and crystal form.Results For microspheres prepared by W/O/W method,an increase in the concentration of both sodium chloride and mannitol in the outer aqueous phase resulted in an increase in drug loading,a decrease in particle size and burst release,and a reduction in surface pores.Sodium chloride instead of mannitol reducted the internal pores of the microspheres.For microspheres prepared by the O/W method,an increase in the concentration of both additives resulted in an increase in drug loading,a decrease in particle size and burst release,and a reduction in both surface and internal pores of the microspheres.Conclusion By increasing the concentration of sodium chloride and mannitol in the outer aqueous phase,the structure and properties of goserelin acetate PLGA microspheres are effectively improved.
作者 郑明秀 刘磊 梁荣财 ZHENG Ming-xiu;LIU Lei;LIANG Rong-cai(School of Pharmacy,Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong,Key Laboratory of Molecular Pharmacology and Drug Evaluation(Yantai University),Ministry of Education,Yantai University,Yantai Shandong 264005;State Key Laboratory of Long-acting and Targeting Drug Delivery System,Shandong Luye Pharmaceutical Co.,Ltd.,Yantai Shandong 264003)
出处 《中南药学》 CAS 2024年第4期960-966,共7页 Central South Pharmacy
关键词 醋酸戈舍瑞林PLGA微球 氯化钠 甘露醇 乳化溶剂挥发法 goserelin acetate PLGA microsphere sodium chloride mannitol emulsified solvent evaporation method
  • 相关文献

参考文献3

二级参考文献32

  • 1郑彩虹,梁文权,虞和永.海藻酸壳聚糖聚乳酸羟乙醇酸复合微球的制备及其对蛋白释放的调节[J].药学学报,2005,40(2):182-186. 被引量:20
  • 2蹇小婷,王莉.肺吸入给药剂型的研究进展[J].西北药学杂志,2005,20(4):185-186. 被引量:7
  • 3Seki T,Kawaguchi T,Endoh H,et al.Controlled release of 3',5'-diester prodrugs of 5-fluoro-2'-deoxyuridine from poly-L-lactic acid microspheres[J].J Pharm Sci,1990,79 (11):985-987.
  • 4Diwan M,Park TG.Pegylation enhances protein stability during encapsulation in PLGA microspheres[J].J Controlled Release,2001,73 (2-3):233-244.
  • 5O'Hagan DT,Jeffery H,Davis SS.The preparation and characterization of poly (lactide-co-glycolide) microparticles:Ⅲ.Microparticle/polymer degradation rates and the in vitro release of a model protein[J].Int J Pharm,1994,103 (1):37-45.
  • 6Raman C,Berkland C,Kim K,et al.Modeling small-molecule release from PLG microspheres:effects of polymer degradation and nonuniform drug distribution[J].J Controlled Release,2005,103(1):149-158.
  • 7Matsumoto A,Matsukawa Y,Suzuki T,et al.Drug release characteristics of multi-reservoir type microspheres with poly (dl-lactide-co-glycolide) and poly (dl-lactide)[J].J Controlled Release,2005,106 (1-2):172-180.
  • 8Rojas J,Pinto-Alphandary H,Leo E,et al.A Polysorbate-based nonionic surfactant can modulate loading and release of β-lactoglobulin entrapped in multiphase poly (DL-lactide-coglycolide) microspheres[J].Pharm Res,1999,16 (2):255-260.
  • 9Wang J,Wang BM,Schwendeman SP.Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly (D,L-lactide-co-glycolide)microspheres[J].Biomaterials,2004,25 (10):1919-1927.
  • 10Takada S,Kurokawa T,Miyazaki K,et al.Utilization of an amorphous form of a water-soluble GPⅡb/Ⅲa antagonist for controlled release from biodegradable microspheres[J].Pharm Res,1997,14(9):1146-1150.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部